Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001078782-15-000181
Filing Date
2015-02-09
Accepted
2015-02-06 19:34:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 424(B)(4) f424b4_424b4.htm 424B4 1160582
2 IMAGE f424b4_424b4002.gif GRAPHIC 824395
3 IMAGE f424b4_424b4003.jpg GRAPHIC 86927
4 IMAGE f424b4_424b4004.jpg GRAPHIC 173934
5 IMAGE f424b4_424b4005.jpg GRAPHIC 73845
6 IMAGE f424b4_424b4006.jpg GRAPHIC 148728
7 IMAGE f424b4_424b4007.jpg GRAPHIC 74690
8 IMAGE f424b4_424b4008.jpg GRAPHIC 84276
9 IMAGE f424b4_424b4009.jpg GRAPHIC 63072
10 IMAGE f424b4_424b4010.jpg GRAPHIC 53816
11 IMAGE f424b4_424b4012.gif GRAPHIC 824395
  Complete submission text file 0001078782-15-000181.txt   4480945
Mailing Address 150 ORCHARD ROAD ORCHARD PLAZA 08-02 U0 238841
Business Address 150 ORCHARD ROAD ORCHARD PLAZA 08-02 U0 238841 000-000-0000
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-200628 | Film No.: 15586389
SIC: 2835 In Vitro & In Vivo Diagnostic Substances